TRIM16 and cardiomyopathy: To further investigate the role of EBBP in anthracycline‐induced cardiomyopathy, AAV‐shEBBP or AAV‐shNC was administered to modulate the expression levels of EBBP prior to doxorubicin treatment (Figure S2C, Supporting Information).